Why Soligenix, Inc. (SNGX) Is Surging 16% In Pre-Market Session?
The biopharmaceutical company Soligenix, Inc. (Nasdaq: SNGX) has been surging +18.63% in the pre-market session today. As of 08:55 a.m. EST, the stock was buoying at $1.88 after gaining +0.27 on the trades of 11.05M shares. What actually happened? Soligenix focuses on developing, manufacturing and selling products for treating unmet medical needs related to rare […]